Lub sijhawm coagulation ib txwm ntawm tib neeg lub cev sib txawv nyob ntawm txoj kev kuaj pom.
Cov hauv qab no yog ntau txoj kev nrhiav pom thiab lawv cov qib siv sib xws:
1 Lub sijhawm ua haujlwm ntawm cov tshuaj thromboplastin ib nrab (APTT):
Feem ntau, lub sijhawm siv ib txwm yog 25-37 vib nas this. APTT feem ntau yog qhia txog kev ua haujlwm ntawm cov yam ntxwv coagulation VIII, IX, XI, XII, thiab lwm yam hauv txoj kev coagulation intrinsic.
2 Lub sijhawm Prothrombin (PT):
Tus nqi siv ib txwm yog 11-13 vib nas this. PT feem ntau yog siv los ntsuas qhov ua haujlwm ntawm cov coagulation factors II, V, VII, X, thiab lwm yam hauv txoj kev coagulation sab nraud.
3 Qhov piv txwv thoob ntiaj teb (INR):
Qhov ntsuas ib txwm muaj yog nruab nrab ntawm 0.8 thiab 1.2. INR yog xam raws li tus nqi PT thiab siv los saib xyuas cov txiaj ntsig kho mob ntawm cov tshuaj anticoagulants hauv qhov ncauj (xws li warfarin) kom ua rau cov txiaj ntsig ntawm kev xeem ntawm ntau lub chaw soj nstuam sib piv.
4 Fibrinogen (FIB):
Qhov ntsuas ib txwm yog 2-4g/L. FIB yog ib hom glycoprotein hauv cov ntshav uas lub siab tsim tawm thiab ua lub luag haujlwm tseem ceeb hauv cov txheej txheem coagulation. Nws hloov mus ua fibrin nyob rau hauv qhov kev ua ntawm thrombin los tsim cov ntshav txhaws.
Yuav tsum nco ntsoov tias cov khoom siv kuaj thiab cov tshuaj reagents ntawm ntau lub chaw soj nstuam sib txawv yuav txawv, thiab cov nqi siv piv txwv ib txwm yuav txawv me ntsis. Tsis tas li ntawd, qee yam kev ua haujlwm ntawm lub cev (xws li hnub nyoog, poj niam txiv neej, cev xeeb tub, thiab lwm yam) thiab cov yam ntxwv pathological (xws li kab mob siab, kab mob ntshav, noj qee yam tshuaj, thiab lwm yam) kuj yuav cuam tshuam rau lub sijhawm coagulation. Yog li ntawd, thaum txhais cov txiaj ntsig ntawm lub sijhawm coagulation, yuav tsum tau ua kev tshuaj xyuas kom meej ua ke nrog tus neeg mob qhov xwm txheej tshwj xeeb.
BEIJING SUCCEEDER TECHNOLOGY INC.
KEV KHO MOB TXOG KEV SIB THOV KOM TXHEEB XYUAS COV KAB MOB COAGULATION
DAIM NTAWV THOV ANALYZER REAGENTS
Beijing Succeeder Technology Inc. (tus lej khoom lag luam: 688338) tau koom nrog tob hauv kev kuaj mob coagulation txij li thaum nws tau tsim tsa xyoo 2003, thiab tau cog lus tias yuav ua tus thawj coj hauv daim teb no. Lub tuam txhab muaj lub hauv paus nyob hauv Beijing, muaj pab pawg R&D, kev tsim khoom thiab kev muag khoom zoo, tsom mus rau kev tsim kho tshiab thiab kev siv cov thev naus laus zis kuaj mob thrombosis thiab hemostasis.
Nrog nws lub zog zoo tshaj plaws, Succeeder tau yeej 45 daim ntawv pov thawj patent, suav nrog 14 daim ntawv pov thawj tsim khoom, 16 daim ntawv pov thawj qauv siv hluav taws xob thiab 15 daim ntawv pov thawj tsim qauv. Lub tuam txhab kuj muaj 32 daim ntawv pov thawj sau npe khoom siv kho mob Class II, 3 daim ntawv pov thawj Class I, thiab daim ntawv pov thawj EU CE rau 14 yam khoom, thiab tau dhau daim ntawv pov thawj ISO 13485 kev tswj hwm zoo kom ntseeg tau tias qhov zoo tshaj plaws thiab ruaj khov ntawm cov khoom zoo.
Succeeder tsis yog tsuas yog ib lub tuam txhab tseem ceeb ntawm Beijing Biomedicine Industry Leapfrog Development Project (G20), tab sis kuj tau tsaws rau ntawm Science thiab Technology Innovation Board hauv xyoo 2020, ua tiav kev loj hlob ntawm lub tuam txhab. Tam sim no, lub tuam txhab tau tsim lub network muag khoom thoob plaws lub tebchaws uas npog ntau pua tus neeg sawv cev thiab chaw ua haujlwm. Nws cov khoom muag tau zoo hauv feem ntau ntawm lub tebchaws. Nws kuj tseem tab tom nthuav dav cov lag luam txawv teb chaws thiab txuas ntxiv txhim kho nws cov kev sib tw thoob ntiaj teb.
Daim npav ua lag luam
Suav WeChat